From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Pediatrics and Adolescent Medicine>
  4. Summary and Comment

Oral Ivermectin: A Good Option for Treatment of Head Lice

It's safe and effective.

Pediculosis capitis (head lice) can lead to school absenteeism and, often, to parental anxiety. Treatment usually involves topical therapy that can be time consuming and painful if excoriations are present. Also, pediculicide resistance is increasing and can lead to treatment failure. Ivermectin is effective for treatment of body lice and scabies, but few studies have evaluated the oral preparation for head lice in children.

In an open-label study, investigators recruited 44 children (age range, 6 to 15 years) living in an indigenous community in Mexico with confirmed head lice and treated them with a single dose of oral ivermectin (200 µg/kg). No nit removal was included in the protocol. One week after treatment, no children had adult live lice. Although 90% of children still had nits, most were nonviable. The 18 children with moderate-to-abundant nits received an additional dose of ivermectin; 1 week later, no viable nits were present. No adverse events were reported.

Comment: Ivermectin is not familiar to most pediatricians but has been used successfully and safely for treatment of several helminths. Although this was a small, open-label trial, the results indicate that ivermectin is a safe and effective pediculicide in children older than 5 years. Currently, resistance to ivermectin is not a concern, making the drug a good addition to the treatment options outlined in the American Academy of Pediatrics revised clinical report on the management of head lice (JW Pediatr Adolesc Med Aug 25 2010). Parents might prefer ivermectin because it is easy to use.

Peggy Sue Weintrub, MD

Published in Journal Watch Pediatrics and Adolescent Medicine December 15, 2010

Citation(s):

Ameen M et al. Oral ivermectin for treatment of pediculosis capitis. Pediatr Infect Dis J 2010 Nov; 29:991.

Reader Remarks:

Review and add to remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Related Content

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2010. Massachusetts Medical Society. All rights reserved.